Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model

Journal of Nuclear Medicine

Volumn 54, Issue 12, 2013, Pages 2111-2117

  Gaertner, Florian C ^a   Wiedemann, Tobias ^b   Yousefi, Behrooz H ^a,c   Lee, Misu ^b   Repokis, Ines ^b   Higuchi, Takahiro ^d   Nekolla, Stephan G ^a   Yu, Ming ^e   Robinson, Simon ^e   Schwaiger, Markus ^a   Pellegata, Natalia S ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e Clinical Research   (United States)

Author keywords

MENX; MIBG; Oncology; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DESIPRAMINE; NORADRENALIN TRANSPORTER; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; [1 [3 BROMO 4 (3 FLOURO PROPOXY)BENZYL]GUANIDINE] F 18; DIAGNOSTIC AGENT; FLUORINE; FLUOROBENZENE; GUANIDINE DERIVATIVE; N (3 BROMO 4 (3 (18F)FLUORO PROPOXY)BENZYL)GUANIDINE; N-(3-BROMO-4-(3-(18F)FLUORO-PROPOXY)BENZYL)GUANIDINE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; FEASIBILITY STUDY; GENE EXPRESSION; HISTOLOGY; IN VIVO STUDY; INTERMETHOD COMPARISON; MULTIPLE ENDOCRINE NEOPLASIA; NET GENE; NONHUMAN; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION MEASUREMENT; RADIOACTIVITY; RADIOISOTOPE DISTRIBUTION; RAT; TUMOR VOLUME; WILD TYPE; 18F-LMI1195; ADRENAL TUMOR; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MENX; MIBG; MUTATION; ONCOLOGY; ORGAN SIZE; PATHOLOGY; SCINTISCANNING; DIAGNOSTIC USE;

18F-LMI1195; MENX; MIBG; ONCOLOGY; PHEOCHROMOCYTOMA;

ADRENAL GLAND NEOPLASMS; ANIMALS; AUTORADIOGRAPHY; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; FLUORINE RADIOISOTOPES; FLUOROBENZENES; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANIDINES; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGAN SIZE; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RATS; TUMOR BURDEN;

EID: 84893360712     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.119966     Document Type: Article

References (24)

1. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology. 1999;53:679-683.
2. Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens (Greenwich). 2002;4:62-72.
3. Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging. 2008;52:419-429.
4. Yu M, Bozek J, Lamoy M, et al. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging. 2011;4:435-443.
5. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med. 1992;33:1125-1131.
6. Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS. 6-[18F] fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension. 2001;38:6-8.
7. Hoegerle S, Nitzsche E, Altehoefer C, et al. Pheochromocytomas: detection with 18F DOPA whole body PET-initial results. Radiology. 2002;222:507-512.
8. Martiniova L, Cleary S, Lai EW, et al. Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma. Nucl Med Biol. 2012;39:215-226.
9. Win Z, Al-Nahhas A, Towey D, et al. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience. Nucl Med Commun. 2007;28:359-363.
10. Yu M, Bozek J, Lamoy M, et al. LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. Eur J Nucl Med Mol Imaging. 2012;39:1910-1919.
11. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA. 2006;103:15558-15563.
12. Fritz A, Walch A, Piotrowska K, et al. Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res. 2002;62:3048-3051.
13. Molatore S, Liyanarachchi S, Irmler M, et al. Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma. Proc Natl Acad Sci USA. 2010;107:18493-18498.
14. Miederer M, Molatore S, Marinoni I, et al. Functional imaging of pheochromocytoma with Ga-DOTATOC and C-HED in a genetically defined rat model of multiple endocrine neoplasia. Int J Mol Imaging. 2011;2011:175352.
15. Shilov M, Frey E, Segars P, Xu J, Tsui B. Improved Monte-Carlo simulations for dynamic PET [abstract]. J Nucl Med. 2006;47(suppl 1):197P.
16. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffinembedded tumor tissue. Am J Pathol. 2001;158:419-429.
17. Verberne HJ, de Bruin K, Habraken JB, et al. No-carrier-added versus carrieradded 123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. Eur J Nucl Med Mol Imaging. 2006;33:483-490.
18. Higuchi T, Yousefi BH, Kaiser F, et al. Assessment of the 18F-labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts. J Nucl Med. 2013; 54:1142-1146.
19. Rischpler C, Fukushima K, Isoda T, et al. Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts. Eur J Nucl Med Mol Imaging. 2013;40:1077-1083.
20. Tomasi G, Turkheimer F, Aboagye E. Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future. Mol Imaging Biol. 2012;14:131-146.
21. Garcia EV. Physical attributes, limitations, and future potential for PET and SPECT. J Nucl Cardiol. 2012;19(suppl 1):S19-S29.
22. Young P, Wilson S, Arch JR. Prolonged beta-adrenoceptor stimulation increases the amount of GDP-binding protein in brown adipose tissue mitochondria. Life Sci. 1984;34:1111-1117.
23. Ghorbani M, Claus TH, Himms-Hagen J. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem Pharmacol. 1997;54: 121-131.
24. Baba S, Engles JM, Huso DL, Ishimori T, Wahl RL. Comparison of uptake of multiple clinical radiotracers into brown adipose tissue under cold-stimulated and nonstimulated conditions. J Nucl Med. 2007;48:1715-1723.